sustained virologic response
Showing 1 - 25 of >10,000
Hepatitis C Trial in Lexington (PREP-C, Modified ECHO, Patient Telemedicine Questionnaire)
Completed
- Hepatitis C
- PREP-C
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 31, 2023
Hepatitis B Trial in Worldwide (GSK3228836)
Recruiting
- Hepatitis B
-
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- +40 more
Jul 28, 2022
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
About Anti-viral Regimen Adjustment on Achieving Complete
Unknown status
- Sustained Virologic Response
- Hepatitis B, Chronic
- only monitoring
- +2 more
-
Chongqing, Chongqing, ChinaThe second affiliated Hospital of Chongqing Medical University
Aug 4, 2021
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 23, 2021
HCV Reinfection in HD Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 22, 2021
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Virologic Response in Participants Newly Diagnosed With HIV-1
Completed
- HIV
- Antiretroviral Therapy
-
Lisboa, PortugalChlo - Hosp. Egas Moniz
Jan 17, 2023
Sustained Threat in Adolescents With Depression
Not yet recruiting
- Depression in Adolescence
- Trier Social Stress Test (TSST)
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Jan 13, 2023
Normal-weight Obesity, Obesity Trial in Stillwater (Exercise tests (VO2 max test and 45-minute exercise session at 65% VO2 max))
Recruiting
- Normal-weight Obesity
- Obesity
- Exercise tests (VO2 max test and 45-minute exercise session at 65% VO2 max)
-
Stillwater, Oklahoma208 Nancy Randolph Davis, Oklahoma State University
Jun 2, 2023
HIV-1 Virologic Response Trial in Durban (DTP, ICM)
Completed
- HIV-1 Virologic Response
- DTP
- ICM
-
Durban, South AfricaTB HIV Care
Nov 18, 2022
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022
Chronic Hepatitis c After Treatment With Direct Action
Completed
- Hepatitis C, Chronic
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021
Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)
Recruiting
- Liver Cirrhosis
- +2 more
- Prolonged-Release Pirfenidone
-
Guadalajara, Jalisco, Mexico
- +1 more
Sep 13, 2022
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021
Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment
Recruiting
- Hepatitis C
- HIV Coinfection
- Low intensity HCV treatment adherence support
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
May 12, 2022
Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)
Terminated
- Hepatitis C, Chronic
- HCV RNA screening
-
Albuquerque, New Mexico
- +1 more
Oct 26, 2022
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir
Not yet recruiting
- Hepatitis C Infection
-
Beijing, Bejing, ChinaBejing Tsinghua Changgung Hospital
Oct 31, 2022
